FDA issues a surprise refusal to review Moderna's mRNA-based flu vaccine filing, despite earlier agreement on trial design.
The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...
You can’t blame this one on the stork. After a brief baby bump early in the COVID-19 pandemic, birth rates in the US and ...
Researchers tracked more than 400 toddlers to see whether mRNA COVID-19 vaccination during or just before pregnancy was linked to autism or developmental delays. After detailed assessments of speech, ...
In a comparison of COVID-19 vaccines, the mRNA vaccine sustained higher anti-S IgG, while the Ad-vector had superior ...
The mRNA COVID-19 vaccine is not associated with autism or other neurodevelopmental problems in children whose mothers ...
COVID-19 vaccination during pregnancy shows no link to autism or developmental delays in young children, according to new ...
Feb 13 (Reuters) - Moderna reported fourth-quarter revenue above Wall Street estimates on Friday, helped by sales of its ...
Mayo Clinic on MSN
Different types of COVID-19 vaccines: How they work
Find out how different vaccines for the coronavirus cause your body to create antibodies that fight the virus.
News-Medical.Net on MSN
Case report examines potential cancer risks after mRNA vaccination
A new case report was published in Volume 17 of Oncotarget on February 6, 2026, titled "Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of ...
Senior FDA official Vinay Prasad reportedly overrode his staff in deciding to reject Moderna's application for a new seasonal flu shot.
The US pharma firm’s 40,000-person study suggested its new shot was more effective than a standard flu vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results